Momentum Is Strong For X4 Pharmaceuticals Inc (NASDAQ: XFOR)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for X4 Pharmaceuticals Inc (XFOR) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.0184, or 2.24%, to $0.8385. The X4 Pharmaceuticals Inc has recorded 14,356 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed XFOR: Update on Phase 2 CN Trial at ASH 2023.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $0.82 and fluctuated between $0.8645 as its day high and $0.8114 as its day low. The current market capitalization of X4 Pharmaceuticals Inc is $137.19M. A total of 0.8 million shares were traded on the day, compared to an average of 2.33M shares.

In the most recent transaction, Ragan Paula sold 39,906 shares of XFOR for 0.90 per share on Nov 03. After the transaction, the President and CEO now owns 836,441 company shares. In a previous transaction on Nov 01, Mostafa Adam S. sold 230,645 shares at 0.73 per share. XFOR shares that Chief Financial Officer owns now total 80,221.

Among the insiders who sold shares, Ragan Paula disposed of 199,531 shares on Nov 01 at a per-share price of $0.73. This resulted in the President and CEO holding 876,347 shares of XFOR after the transaction. In another insider transaction, DiBiase Mary sold 67,695 shares at $0.73 per share on Nov 01. Company shares held by the Chief Operating Officer now total 310,844.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for XFOR in the last 3 months, the mean price target is $3.26 with high estimates of $5.00 and low estimates of $1.00. In terms of 52-week highs and lows, XFOR has a high of $2.58 and a low of $0.57.

As of this writing, XFOR has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.14 per share and a lower estimate of -$0.17. The company reported an EPS of -$0.33 in the last quarter, which was -106.20% lower than expectations of -$0.16.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. XFOR’s latest balance sheet shows that the firm has $81.79M in Cash & Short Term Investments as of fiscal 2021. There were $39.78M in debt and $14.02M in liabilities at the time. Its Book Value Per Share was $0.41, while its Total Shareholder’s Equity was $64.41M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XFOR is Buy with a score of 4.71.

Most Popular

Related Posts